Health Care
Featured
NEW BRIEF: 340B Hospitals More Profitable, Provide Less Charity Care, Receive Unwarranted Subsidies
So-called 340B hospitals whose mission is to help the vulnerable are more profitable and provide less charity care, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute, a California-based, free-market think tank. Click to download “Profiting from 340B” “The ...
Wayne H Winegarden
November 10, 2021
Commentary
U.S. Bureaucrats Are An Impediment To Pandemic Recovery
Late last month, the Biden administration announced a new initiative to lower the cost of at-home Covid-19 tests and make them more widely available. It’s long past time. Throughout the pandemic, bureaucratic sclerosis has proven the American regulatory apparatus to be an impediment to fighting Covid-19—not to mention future public health threats. ...
Sally C. Pipes
November 8, 2021
Blog
Get Ready for Another Big California Spending Spree
Governor Newsom let the cat of the bag recently in an interview at the Milken Institute’ annual conference – California is going to see another of what he calls a “historic budget surplus” next year. The Sacramento Bee reports that “in addition a surplus for next year’s budget, Newsom said ...
Tim Anaya
November 8, 2021
Commentary
Democrats Abandon US Patients to Rescue Drug-Pricing Reform
Just a few days ago, it appeared that Democrats had given up on including prescription drug pricing reforms in their massive spending bill. But not anymore. In an eleventh-hour turn of events, congressional Democrats this week resurrected their long-standing desire to levy government price controls on prescription drugs. If lawmakers successfully deploy their latest ...
Sally C. Pipes
November 4, 2021
Health Care
NEW BRIEF: U.S. Patients Could Save Up to $5.8 Billion Through Competition from Humira and Enbrel Biosimilars
Policies that promote biosimilar competition have the potential to save U.S. patients up to $5.8 billion collectively if biosimilars to Humira and Enbrel grow in market share, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute, a California-based, free-market ...
Wayne H Winegarden
November 3, 2021
Commentary
Biden’s new plan isn’t any better for your health
Last week, President Joe Biden unveiled a new social spending framework that omitted many of the healthcare provisions Democrats have been calling for. One provision that has survived is a massive and wasteful expansion of Obamacare . In March, Congress made federal tax credits available to those shopping for coverage on the exchanges with ...
Sally C. Pipes
November 1, 2021
Blog
Getting the Drug Spending Facts Right
In a typical rant, Senator Sanders claimed in a September 15th press release that “at a time when the drug companies are charging us by far the highest prices in the world, Congress must demand that Medicare negotiate prices with this extremely greedy and powerful industry.” The Senator clearly misunderstands ...
Wayne Winegarden
October 29, 2021
Business & Economics
Jon Miltimore – The Push for Socialism and Economic Restrictions in the Name of the Pandemic
Enjoy this recent conversation between Jon Miltimore of the Foundation for Economic Education and PRI’s Evan Harris for our Young Leaders Circle Speaker Series. They discuss socialism, progressive politics, economic news, and the latest pandemic restrictions.
Pacific Research Institute
October 25, 2021
Commentary
Single-Payer Will Worsen Healthcare Workers’ Plight
Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what’s been called “Striketober,” frontline staff are walking out of hospitals, emergency rooms, and doctor’s offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted to authorize a strike over ...
Sally C. Pipes
October 25, 2021
Coronavirus
Dr. Henry Miller Explains COVID Rapid Tests with Lars Larson
Dr. Henry Miller, M.S., M.D., joins the nationally-syndicated Lars Larson Show to talk about how the U.S. Food and Drug Administration, FDA, blocked a crucial test, the rapid response antigen test, to help with COVID-19 testing. The test is an at-home test that takes roughly 20 minutes. Dr. Miller explains ...
Henry Miller, M.S., M.D.
October 21, 2021
NEW BRIEF: 340B Hospitals More Profitable, Provide Less Charity Care, Receive Unwarranted Subsidies
So-called 340B hospitals whose mission is to help the vulnerable are more profitable and provide less charity care, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute, a California-based, free-market think tank. Click to download “Profiting from 340B” “The ...
U.S. Bureaucrats Are An Impediment To Pandemic Recovery
Late last month, the Biden administration announced a new initiative to lower the cost of at-home Covid-19 tests and make them more widely available. It’s long past time. Throughout the pandemic, bureaucratic sclerosis has proven the American regulatory apparatus to be an impediment to fighting Covid-19—not to mention future public health threats. ...
Get Ready for Another Big California Spending Spree
Governor Newsom let the cat of the bag recently in an interview at the Milken Institute’ annual conference – California is going to see another of what he calls a “historic budget surplus” next year. The Sacramento Bee reports that “in addition a surplus for next year’s budget, Newsom said ...
Democrats Abandon US Patients to Rescue Drug-Pricing Reform
Just a few days ago, it appeared that Democrats had given up on including prescription drug pricing reforms in their massive spending bill. But not anymore. In an eleventh-hour turn of events, congressional Democrats this week resurrected their long-standing desire to levy government price controls on prescription drugs. If lawmakers successfully deploy their latest ...
NEW BRIEF: U.S. Patients Could Save Up to $5.8 Billion Through Competition from Humira and Enbrel Biosimilars
Policies that promote biosimilar competition have the potential to save U.S. patients up to $5.8 billion collectively if biosimilars to Humira and Enbrel grow in market share, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute, a California-based, free-market ...
Biden’s new plan isn’t any better for your health
Last week, President Joe Biden unveiled a new social spending framework that omitted many of the healthcare provisions Democrats have been calling for. One provision that has survived is a massive and wasteful expansion of Obamacare . In March, Congress made federal tax credits available to those shopping for coverage on the exchanges with ...
Getting the Drug Spending Facts Right
In a typical rant, Senator Sanders claimed in a September 15th press release that “at a time when the drug companies are charging us by far the highest prices in the world, Congress must demand that Medicare negotiate prices with this extremely greedy and powerful industry.” The Senator clearly misunderstands ...
Jon Miltimore – The Push for Socialism and Economic Restrictions in the Name of the Pandemic
Enjoy this recent conversation between Jon Miltimore of the Foundation for Economic Education and PRI’s Evan Harris for our Young Leaders Circle Speaker Series. They discuss socialism, progressive politics, economic news, and the latest pandemic restrictions.
Single-Payer Will Worsen Healthcare Workers’ Plight
Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what’s been called “Striketober,” frontline staff are walking out of hospitals, emergency rooms, and doctor’s offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted to authorize a strike over ...
Dr. Henry Miller Explains COVID Rapid Tests with Lars Larson
Dr. Henry Miller, M.S., M.D., joins the nationally-syndicated Lars Larson Show to talk about how the U.S. Food and Drug Administration, FDA, blocked a crucial test, the rapid response antigen test, to help with COVID-19 testing. The test is an at-home test that takes roughly 20 minutes. Dr. Miller explains ...